The Indian government on Tuesday approved 10 FDI proposals amounting to Rs.607 crore, based on the recommendations of the Foreign Investment Promotion Board (FIPB).
The approved proposals were from Atria Convergence Technologies, Glenmark Pharmaceuticals, Euronet Services India, Emcure Pharmaceuticals and AvH Resources India.
The approved list also included FDI proposals from Cipla, Alstom Manufacturing India, Capricorn Ventures, DEN Networks and Celestis Pharmaceuticals.
Of the approved proposals, the highest proposal emerged from Alstom Manufacturing India at Rs.400 crore, followed by Cipla's Rs.145.22 crore.
Another FDI proposal amounting to Rs.5,856.51 crore has been recommended to be approved by the Cabinet Committee on Economic Affairs (CCEA) while five proposals from Ashedene Investments, Veritas (India), KDK Softwares, Kemefs Specialities and Afro Asia Equipments were rejected.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app